The expression of N-glycan on the surface of different tumor types is heterogeneous, and the varying binding ability of Dectin-1 to various tumor N-glycan structures may lead to differences in DC, macrophage-induced, and NK-mediated tumoricidal effects [16]. Here, CLEC7A is linked to neoplasm.